From the news

Recent transaction and litigation


November / 2011

Advising Cisco in Intended Acquisition of NDS Group for approximately $5 Billion

Meitar acted as local counsel for Cisco in its intended acquisition of NDS Group, a leading provider of video software and content security solutions for approximately $5 billion. The transaction is expected to be completed during the second half of 2012.

November / 2011

Representation of Objet in its $3 billion merger with Stratasys

Meitar represented Objet, an Israel-based manufacturer of 3D printers, in a contemplated IPO on NASDAQ, which in its advanced stages was deferred, in a dual-tracking process, in favor of entering into an all-stock merger of equals with Stratasys, a Delaware corporation (NASDAQ:SSYS). Under this innovative structure, the shares of the publicly traded Stratasys will be exchanged for shares in the currently privately-held Objet. At closing, Objet will simultaneously become the parent company of the merged entities and, for the first time, a publicly traded company on NASDAQ.

November / 2011

Covidien in its acquisition of Oridion Systems Ltd.

Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of Oridion Systems Ltd., an Israeli company and a global leader in capnography monitoring, for $346 million in cash. The transaction is expected to be completed during the second quarter of 2012.

November / 2011

Representation of Broadlight in its acquisition by Broadcom for approximately $220 million

Meitar represented Broadlight a provider of highly integrated networking and fiber access PON (Passive Optical Network) processors in its acquisition by Broadcom Corporation a global leader in semiconductor solutions for wired and wireless communications for approximately $220 million. The transaction was completed on April 5, 2012.

November / 2011

Representation of Facebook in its acquisition of

Our firm, together with US-based Fenwick & West LLP, represented Facebook, Inc. (NASDAQ: FB) in the acquisition of, the developer of a leading face-recognition technology. Financial terms of the transaction were not disclosed.

November / 2011

Representation of Surpass Medical in its acquisition by Stryker for $135 million

Meitar represented privately-held Surpass Medical Ltd., a developer of next-generation flow diversion stent technology to treat brain aneurysms using a unique mesh design and delivery system in its acquisition by Stryker Corporation for up to $135 million, in an all cash transaction.

November / 2011

Representation of the controlling shareholder of HOT Telecommunication Systems

As part of the transaction, the controlling shareholder purchased the shares of Hot, Israel’s leading cable television company, held by the public in a reverse triangular merger. The controlling shareholder financed the purchase through the issuance of bonds to a syndicate of international banks. These transactions were the last part of the establishment of a leading telecom group in Israel, after purchasing the cellular carrier HOT Mobile (formerly Mirs) from Motorola, and gradually increasing the holdings of the controlling shareholders in HOT over the last three years. The total transaction value, including other share purchases by the controlling shareholder, was $1.1 billion.